BML-111 could increase the level of SIRT1 and then inhibit the activation of NF-κB signaling pathway, which at last alleviated the activation of glias, mitigated neuroinflammation, decreased the number of apoptosis cells and improved cognitive impairment (Figure 13H). The gene discussed is SIRT1; the disease is Cognitive impairment.